Senator DUNIAM (Tasmania—Assistant Minister for Forestry and Fisheries and Assistant Minister for Regional Tourism) (16:13): I seek leave to make a short statement. The PRESIDENT: Leave is granted for one minute. Senator DUNIAM: The government is committed to affordable access to medicines under the mechanism stipulated by the law. Since January 2016, over 14,000 applications for medicinal cannabis have been approved by the Special Access Scheme, the SAS, which is overseen by the Therapeutic Goods Administration, the TGA. Until domestic production meets local need, the government will authorise controlled importation by approved providers from approved international sources to enable an interim inventory in Australia. A recent study conducted by FreshLeaf Analytics, released in March this year, shows that the prices of most Australian medicinal cannabis products decreased by a further 26 per cent in the six months to March 2019.